Korea’s 36 listed or non-listed drug firms recorded more than 100 billion won in sales last year, data showed Friday.
Combined sales by the 36 companies rose 3 percent to 9.84 trillion won in the fiscal year 2012, according to Yakup.com, a pharmaceutical information provider.
Their operating profits fell 18 percent to 724.5 billion won during the same time span, Yakup.com said, adding the...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.